Arbutus Biopharma (ABUS) PT Raised to $5 at JMP Securities
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $4.69 -0.42%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
JMP Securities analyst Roy Buchanan raised the price target on Arbutus Biopharma (NASDAQ: ABUS) to $5.00 (from $4.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Planet Fitness (PLNT) PT Raised to $51 at Morgan Stanley
- Scorpio Tankers (STNG) PT Lowered to $76 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
